Skip to main content
Article thumbnail
Location of Repository

Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence

By A.J. Kooter, P.J. Kostense, J. Groenewold, A. Thijs, N. Sattar and Y.M. Smulders
Topics: R1
Publisher: American Heart Association
Year: 2011
OAI identifier:
Provided by: Enlighten

Suggested articles


  1. (2008). Assessing new biomarkers and predictive models for use in clinical practice. Arch Intern Med. doi
  2. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. doi
  3. Cardiovascular and coronary risk estimation in hypertension management. doi
  4. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. doi
  5. (2011). Emerging risk factors for coronary heart disease: a 744 Circulation August 9, doi
  6. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. doi
  7. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin doi
  8. (1998). Prediction of coronary heart disease using risk factor categories. Circulation. doi
  9. (2011). risk factors epidemiology cardiovascular diseases Kooter et al “Novel Risk Factors, Relative Risks Are Not Enough” 745 at
  10. SCORE project group. Estimation of ten year risk of fatal cardiovascular disease in Europe: the SCORE project. doi
  11. (2004). Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. doi
  12. (2000). The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. doi
  13. What does my patient’s coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk.
  14. (1992). What price perfection? Calibration and discrimination of clinical prediction models. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.